Healthcare Triangle Inc Signs LOI to Acquire Roboticom's Industrial Automation Business

PLEASANTON, Calif., Sept. 23, 2026 /CourierPR/ -- Healthcare Triangle, Inc., a leading provider of technology solutions for the healthcare industry, has announced a significant move into the industrial automation sector. The company has signed a non-binding Letter of Intent (LOI) with Crestpoint Capital LLC to acquire certain intellectual property, trademarks, and business assets associated with Roboticom, a Pisa, Italy-based provider of industrial robotic automation systems.

Roboticom specializes in precision surface treatment and serves a diverse range of industries including aerospace, marine, composites, orthotics and prosthetics, and industrial tooling. The company's products, marketed under the SandRob™, ORTIS™, and ScultoRob™ brands, are designed to enhance the efficiency and precision of various manufacturing processes.

According to unaudited financial information provided by Roboticom's current ownership group, the business generated approximately $14.1 million in revenue and $6.9 million in gross margin for the fiscal year 2025. Roboticom's management has prepared a five-year Growth and Operating Plan targeting the business to reach approximately $153.5 million in revenue and $64 million in adjusted operating contribution by fiscal year 2029/30. However, HCTI notes that these projections are unaudited, unverified, and subject to significant uncertainty.

Healthcare Triangle, Inc., based in Pleasanton, California, believes that the acquisition could extend its technology platform beyond healthcare into industrial automation and advanced manufacturing. The company's Cloud and Data Platform (CaDP), marketed as CloudEz™ and DataEz™, has achieved HITRUST Risk-based, 2-year (r2) Certified status, demonstrating to clients the highest standards for data protection and information security.

The proposed transaction, which would see HCTI acquire 100% of the customer contracts, identified intellectual property, trademarks, and business assets for a total consideration of up to $30 million in cash and equity, is subject to due diligence, satisfactory title confirmation, and other conditions.

The acquisition, if consummated, would allow HCTI to leverage its existing artificial intelligence, cloud, and data capabilities with Roboticom's established industrial robotics platform, potentially opening new markets and driving growth in both sectors. However, HCTI cautions that there is no assurance that the proposed transaction will be completed on the terms described or at all, and that actual results may differ materially from the projections provided by Roboticom management.